Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Atrasorb is a Brazilian manufacturer of carbon dioxide absorbents and related respiratory-system products used primarily in inhalation anesthesia. The company states that it pioneered the domestic CO2 absorber segment in Brazil in 1989 and today serves medicinal, military, diving, and industrial markets. In healthcare, its core products include Atrasorb Pharma, Atrasorb Pharma Fix, and Atrasorb Pharma Free, which are used in anesthesia circuits to remove carbon dioxide in closed or semi-closed breathing systems. The company operates as a regulated health-products manufacturer with ANVISA registrations and quality certifications including ISO 13485. Atrasorb appears to be a commercial-stage medical products company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Atrasorb.